Association between Psoriasis Disease and IFN-λ Gene Polymorphisms

References

• Afdhal NH, McHutchison JG, Zeuzem S, Mangia A, Pawlotsky JM, Murray JS, Shianna KV, Tanaka Y, Thomas DL, Booth DR, et al., Pharmacogenetics and Hepatitis C Meeting Participants. 2011. Hepatitis C pharmacogenetics: state of the art in 2010. Hepatology (Baltimore, Md). 53(1):336–45. doi:10.1002/hep.24052.
   PubMed Web of Science ®Google Scholar
• Arpaci D, Karakas Celik S, Can M, Cakmak Genc G, Kuzu F, Unal M, Bayraktaroglu T. 2016. Increased serum levels of IL-28 and IL-29 and the protective effect of IL28B rs8099917 polymorphism in patients with Hashimoto’s thyroiditis. Immunol Invest. 45(7):668–78.
   PubMed Web of Science ®Google Scholar
• Boehncke WH, Schön MP. 2015. Psoriasis. Lancet (London, England). 386(9997):983–94.
   PubMed Web of Science ®Google Scholar
• Cakmak Genc G, Dursun A, Karakas Celik S, Calik M, Kokturk F, Piskin IE. 2018. IL28B, IL29 and micro-RNA 548 in subacute sclerosing panencephalitis as a rare disease. Gene. 678:73–78.
   PubMed Web of Science ®Google Scholar
• Cakmak Genc G, Karakas Celık S, Kocaaga A, Koca R, Dursun A. 2020. Association between IL28B, IL29 gene polymorphisms and clinical manifestations of Behçet’s disease. Immunol Invest. 1–8. Advance online publication. doi:10.1080/08820139.2020.1791176.
   Web of Science ®Google Scholar
• Cardoso PR, Lima EV, Lima MM, Rêgo MJ, Marques CD, Pitta I, Duarte AL, Pitta MG. 2016. Clinical and cytokine profile evaluation in Northeast Brazilian psoriasis plaque-type patients. Eur Cytokine Netw. 27(1):1–5.
   PubMed Web of Science ®Google Scholar
• Chen JY, Wang CM, Chen TD, Jan Wu YJ, Lin JC, Lu LY, Wu J. 2018. Interferon-λ3/4 genetic variants and interferon-λ3 serum levels are biomarkers of lupus nephritis and disease activity in Taiwanese. Arthritis Res Ther. 20(1):193.
   PubMedGoogle Scholar
• Chun K, Afshar M, Audish D, Kabigting F, Paik A, Gallo R, Hata T. 2017. Hepatitis C may enhance key amplifiers of psoriasis. J Eur Acad Dermatol Venereol: JEADV. 31(4):672–78.
   PubMed Web of Science ®Google Scholar
• Chyuan IT, Tzeng HT, Chen JY. 2019. Signaling pathways of type I and type III interferons and targeted therapies in systemic lupus erythematosus. Cells. 8(9):963.
   PubMed Web of Science ®Google Scholar
• Clark RA. 2013. Human skin in the game. Sci Transl Med. 5(204): 204ps13.
   PubMed Web of Science ®Google Scholar
• Ferrari SM, Ruffilli I, Colaci M, Antonelli A, Ferri C, Fallahi P. 2015. CXCL10 in psoriasis. Adv Med Sci. 60(2):349–54.
   PubMed Web of Science ®Google Scholar
• Fredriksson T, Pettersson U. 1978. Severe psoriasis–oral therapy with a new retinoid. Dermatologica. 157(4):238–44.
   PubMedGoogle Scholar
• Galimova E, Akhmetova V, Latipov B, Kingo K, Rätsep R, Traks T, Kõks S, Khusnutdinova E. 2012. Analysis of genetic variants of class II cytokine and their receptor genes in psoriasis patients of two ethnic groups from the Volga-Ural region of Russia. J Dermatol Sci. 68(1):9–18.
   PubMed Web of Science ®Google Scholar
• Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, et al. 2009. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature. 461(7262):399–401.
   PubMed Web of Science ®Google Scholar
• Graber JJ, Dhib-Jalbut S. 2014. Interferons. In: Aminoff MJ, Daroff RB, editors. Encyclopedia of the neurological sciences. 2nd ed. Academic Press. p. 718–23. doi:10.1016/B978-0-12-385157-4.00182-2.
   Google Scholar
• Grine L, Dejager L, Libert C, Vandenbroucke RE. 2015. An inflammatory triangle in psoriasis: TNF, type I IFNs and IL-17. Cytokine Growth Factor Rev. 26(1):25–33.
   PubMed Web of Science ®Google Scholar
• Haque M, Siegel RJ, Fox DA, Ahmed S. 2021. Interferon-stimulated GTPases in autoimmune and inflammatory diseases: promising role for the guanylate-binding protein (GBP) family. Rheumatology (Oxford, England). 60(2):494–506.
   PubMed Web of Science ®Google Scholar
• Honda M, Sakai A, Yamashita T, Nakamoto Y, Mizukoshi E, Sakai Y, Yamashita T, Nakamura M, Shirasaki T, Horimoto K, et al., Hokuriku Liver Study Group. 2010. Hepatic ISG expression is associated with genetic variation in interleukin 28B and the outcome of IFN therapy for chronic hepatitis C. Gastroenterology. 139(2):499–509. doi:10.1053/j.gastro.2010.04.049.
   PubMed Web of Science ®Google Scholar
• Jiménez-Sousa MA, Fernández-Rodríguez A, Guzmán-Fulgencio M, García-Álvarez M, Resino S. 2013. Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C. BMC Med. 11:6.
   PubMed Web of Science ®Google Scholar
• Jin G, Kang H, Chen X, Dai D. 2014. Evaluation of the relationship between IL28B, IL10RB and IL28RA single-nucleotide polymorphisms and susceptibility to hepatitis C virus in Chinese Han population. Infect Genet Evol. 21:8–14.
   PubMed Web of Science ®Google Scholar
• Krueger JG, Wharton KA Jr, Schlitt T, Suprun M, Torene RI, Jiang X, Wang CQ, Fuentes-Duculan J, Hartmann N, Peters T, et al. 2019. IL-17A inhibition by secukinumab induces early clinical, histopathologic, and molecular resolution of psoriasis. J Allergy Clin Immunol. 144(3):750–63.
   PubMed Web of Science ®Google Scholar
• Lazear HM, Nice TJ, Diamond MS. 2015. Interferon-λ: immune functions at barrier surfaces and beyond. Immunity. 43(1):15–28.
   PubMed Web of Science ®Google Scholar
• Li Y, Cheng H, Zuo XB, Sheng YJ, Zhou FS, Tang XF, Tang HY, Gao JP, Zhang Z, He SM, et al. 2013. Association analyses identifying two common susceptibility loci shared by psoriasis and systemic lupus erythematosus in the Chinese Han population. J Med Genet. 50(12):812–18.
   PubMed Web of Science ®Google Scholar
• Liu Y, Cui SN, Duan MY, Dou ZL, Li YZ, Liu YX, Xia Y, Zhang JW, Yan XN, Han DR, et al. 2021 March 1. Is there a relationship between psoriasis and hepatitis C?: a meta-analysis and bioinformatics investigation. Virol J. 18. PREPRINT (Version 1) available at Research Square. doi:10.21203/rs.3.rs-249926/v1.
   Web of Science ®Google Scholar
• Lockshin B, Balagula Y, Merola JF. 2018. Interleukin 17, inflammation, and cardiovascular risk in patients with psoriasis. J Am Acad Dermatol. 79(2):345–52.
   PubMed Web of Science ®Google Scholar
• Manry J, Laval G, Patin E, Fornarino S, Itan Y, Fumagalli M, Sironi M, Tichit M, Bouchier C, Casanova JL, et al. 2011. Evolutionary genetic dissection of human interferons. J Exp Med. 208(13):2747–59.
   PubMed Web of Science ®Google Scholar
• Melis R, Fauron C, McMillin G, Lyon E, Shirts B, Hubley LM, Slev PR. 2011. Simultaneous genotyping of rs12979860 and rs8099917 variants near the IL28B locus associated with HCV clearance and treatment response. J Mol Diagn: MD. 13(4):446–51.
   PubMed Web of Science ®Google Scholar
• Metwally M, Thabet K, Bayoumi A, Nikpour M, Stevens W, Sahhar J, Zochling J, Roddy J, Tymms K, Strickland G, et al. 2019. IFNL3 genotype is associated with pulmonary fibrosis in patients with systemic sclerosis. Sci Rep. 9(1):14834.
   PubMedGoogle Scholar
• Perera GK, Di Meglio P, Nestle FO. 2012. Psoriasis. Annu Rev Pathol. 7:385–422.
   PubMed Web of Science ®Google Scholar
• Rendon A, Schäkel K. 2019. Psoriasis pathogenesis and treatment. Int J Mol Sci. 20(6):1475.
   PubMed Web of Science ®Google Scholar
• Sarvari J, Mansouri M, Hashempoor T, Hosseini SY, Moattari A, Pirbonyeh N, Dowran R, Moayedi J, Musavi Z, Fattahi M-R, et al. 2017. Association of genotype and haplotype of IL-28B gene with hepatitis c infection outcome in Iran: spontaneous clearance versus chronic infection. Hepat Mon. 17(5):e45745. doi:10.5812/hepatmon.45745.
   Web of Science ®Google Scholar
• Saunte DM, Mrowietz U, Puig L, Zachariae C. 2017. Candida infections in patients with psoriasis and psoriatic arthritis treated with interleukin-17 inhibitors and their practical management. Br J Dermatol. 177(1):47–62.
   PubMed Web of Science ®Google Scholar
• Sheppard P, Kindsvogel W, Xu W, Henderson K, Schlutsmeyer S, Whitmore TE, Kuestner R, Garrigues U, Birks C, Roraback J, et al. 2003. IL-28, IL-29 and their class II cytokine receptor IL-28R. Nat Immunol. 4(1):63–68.
   PubMed Web of Science ®Google Scholar
• Shoeib MA, El-Shafey EN, Sonbol AA, Radwan Lashin SE. 2015. Assessment of serum interferon-γ in psoriasis. Menoufia Med J. 28:488–93.
   Google Scholar
• Smith KR, Suppiah V, O’Connor K, Berg T, Weltman M, Abate ML, Spengler U, Bassendine M, Matthews G, Irving WL, et al., International Hepatitis C Genetics Consortium (IHCGC). 2011. Identification of improved IL28B SNPs and haplotypes for prediction of drug response in treatment of hepatitis C using massively parallel sequencing in a cross-sectional European cohort. Genome Med. 3(8):57. doi:10.1186/gm273.
   PubMedGoogle Scholar
• Theodorakopoulou E, Yiu ZZ, Bundy C, Chularojanamontri L, Gittins M, Jamieson LA, Motta L, Warren RB, Griffiths CE. 2016. Early- and late-onset psoriasis: a cross-sectional clinical and immunocytochemical investigation. Br J Dermatol. 175(5):1038–44.
   PubMed Web of Science ®Google Scholar
• Volpe E, Servant N, Zollinger R, Bogiatzi SI, Hupé P, Barillot E, Soumelis V. 2008. A critical function for transforming growth factor-beta, interleukin 23 and proinflammatory cytokines in driving and modulating human T(H)-17 responses. Nat Immunol. 9(6):650–57.
   PubMed Web of Science ®Google Scholar
• Witte E, Kokolakis G, Witte K, Warszawska K, Friedrich M, Christou D, Kirsch S, Sterry W, Volk HD, Sabat R, et al. 2016. Interleukin-29 induces epithelial production of CXCR3A ligands and T-cell infiltration. J Mol Med (Berlin, Germany). 94(4):391–400.
   PubMed Web of Science ®Google Scholar
• Witte K, Gruetz G, Volk HD, Looman AC, Asadullah K, Sterry W, Sabat R, Wolk K. 2009. Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines. Genes Immun. 10(8):702–14.
   PubMed Web of Science ®Google Scholar
• Wolk K, Witte K, Witte E, Raftery M, Kokolakis G, Philipp S, Schönrich G, Warszawska K, Kirsch S, Prösch S, et al. 2013. IL-29 is produced by T(H)17 cells and mediates the cutaneous antiviral competence in psoriasis. Sci Transl Med. 5(204):204ra129.
   PubMed Web of Science ®Google Scholar
• Xu M, Lu H, Lee YH, Wu Y, Liu K, Shi Y, An H, Zhang J, Wang X, Lai Y, et al. 2018. An interleukin-25-mediated autoregulatory circuit in keratinocytes plays a pivotal role in psoriatic skin inflammation. Immunity. 48(4):787–798.e4.
   PubMed Web of Science ®Google Scholar